|
1
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu H, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: the avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010.PubMed/NCBI
|
|
2
|
Yang L, Lin C, Wang L, Guo H and Wang X:
Hypoxia and hypoxia-inducible factors in glioblastoma multiforme
progression and therapeutic implications. Exp Cell Res.
318:2417–2426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reya T, Morrison SJ, Clarke MF and
Weissman1 IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
5
|
Fan X, Salford LG and Widegren B: Glioma
stem cells: evidence and limitation. Semin Cancer Biol. 17:214–218.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin X, Jin X, Jung JE, Beck S and Kim H:
Cell surface Nestin is a biomarker for glioma stem cells. Biochem
Biophys Res Commun. 433:496–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He J, Shan Z, Li L, Liu F, Liu Z, Song M
and Zhu H: Expression of glioma stem cell marker CD133 and
O6-methylguanine-DNA methyltransferase is associated with
resistance to radiotherapy in gliomas. Oncol Rep. 26:1305–1313.
2011.PubMed/NCBI
|
|
8
|
Park D, Xiang AP, Mao FF, et al: Nestin is
required for the proper self-renewal of neural stem cells. Stem
Cells. 28:2162–2171. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park DM and Rich JN: Biology of glioma
cancer stem cells. Mol Cells. 28:7–12. 2009. View Article : Google Scholar
|
|
10
|
Shmelkov SV, St Clair R, Lyden D and Rafii
S: AC133/CD133/ Prominin-1. Int J Biochem Cell Biol. 37:715–719.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
12
|
Johannessen TC, Bjerkvig R and Tysnes BB:
DNA repair and cancer stem-like cells - potential partners in
glioma drug resistance. Cancer Treat Rev. 34:558–567. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alam J and Stewart D: Nrf2, a Cap’n’Collar
transcription factor, regulates induction of the heme oxygenase-1
gene. J Biol Chem. 274:26071–26078. 1999.
|
|
14
|
Kensler TW, Wakabayashi N and Biswal S:
Cell survival responses to environmental stresses via the
Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 47:89–116.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim HJ, Zheng M, Kim SK, Cho JJ, Shin CH,
Joe Y and Chung HT: CO/HO-1 induces NQO-1 expression via Nrf2
activation. Immune Netw. 11:376–382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Piao MS, Choi JY, Lee DH, Yun SJ, Lee JB
and Lee SC: Differentiation-dependent expression of NADP(H):quinone
oxidoreductase-1 via NF-E2 related factor-2 activation in human
epidermal keratinocytes. J Dermatol Sci. 62:147–153. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji L, Li H, Gao P, Shang G, Zhang DD,
Zhang N and Jiang T: Nrf2 pathway regulates
multidrug-resistance-associated protein 1 in small cell lung
cancer. PLoS One. 8:e634042013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsai JJ, Dudakov JA, Takahashi K, et al:
Nrf2 regulates haematopoietic stem cell function. Nat Cell Biol.
15:309–316. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang XJ, Sun Z, Villeneuve NF, et al: Nrf2
enhances resistance of cancer cells to chemotherapeutic drugs, the
dark side of Nrf2. Carcinogenesis. 29:1235–1243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lau A, Villeneuve NF, Sun Z, Wong PK and
Zhang DD: Dual roles of Nrf2 in cancer. Pharmacol Res. 58:262–270.
2008. View Article : Google Scholar
|
|
21
|
Zhu J, Wang H, Sun Q, et al: Nrf2 is
required to maintain the self-renewal of glioma stem cells. BMC
Cancer. 13:3802013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vescovi AL, Galli R and Reynolds BA: Brain
tumour stem cells. Nat Rev Cancer. 6:425–436. 2006. View Article : Google Scholar
|
|
23
|
Venere M, Fine HA, Dirks PB and Rich JN:
Cancer stem cells in gliomas: identifying and understanding the
apex cell in cancer’s hierarchy. Glia. 59:1148–1154.
2011.PubMed/NCBI
|
|
24
|
Stiles CD and Rowitch DH: Glioma stem
cells: a midterm exam. Neuron. 58:832–846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cullinan SB, Zhang D, Hannink M, et al:
Nrf2 is a direct PERK substrate and effector of PERK-dependent cell
survival. Mol Cell Biol. 23:7198–7209. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iida K, Itoh K, Kumagai Y, et al: Nrf2 is
essential for the chemopreventive efficacy of oltipraz against
urinary bladder carcinogenesis. Cancer Res. 64:6424–6431. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh A, Misra V, Thimmulappa RK, et al:
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
PLoS Med. 3:e4202006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ikeda H, Nishi S and Sakai M:
Transcription factor Nrf2/MafK regulates rat placental glutathione
S-transferase gene during hepatocarcinogenesis. Biochem J.
380:515–521. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pan H, Wang H, Zhu L, Wang X, Cong Z, Sun
K and Fan Y: The involvement of Nrf2-ARE pathway in regulation of
apoptosis in human glioblastoma cell U251. Neurol Res. 35:71–78.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ji XJ, Chen SH, Zhu L, et al: Knockdown of
NF-E2-related factor 2 inhibits the proliferation and growth of
U251MG human glioma cells in a mouse xenograft model. Oncol Rep.
30:157–164. 2013.PubMed/NCBI
|
|
31
|
Park EJ, Lim JH, Nam SI, Park JW and Kwon
TK: Rottlerin induces heme oxygenase-1 (HO-1) up-regulation through
reactive oxygen species (ROS) dependent and PKC delta-independent
pathway in human colon cancer HT29 cells. Biochimie. 92:110–115.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim JE, Kang YJ, Lee KY and Choi HC:
Isoproterenol inhibits angiotensin II-stimulated proliferation and
reactive oxygen species production in vascular smooth muscle cells
through heme oxygenase-1. Biol Pharm Bull. 32:1047–1052. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsieh HL, Wang HH, Wu CY and Yang CM:
Reactive oxygen species-dependent c-Fos/activator protein 1
induction upregulates heme oxygenase-1 expression by bradykinin in
brain astrocytes. Antioxid Redox Signal. 13:1829–1844. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
DeNicola GM, Karreth FA, Humpton TJ, et
al: Oncogene-induced Nrf2 transcription promotes ROS detoxification
and tumorigenesis. Nature. 475:106–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
